XXXXXXXXX XXXXXXXXXX XXXXXX (XX) 2020/528
ze dne 14. xxxxx 2020,
xxxxxx xx xxxxxxxxx xxxxxxxxxx x Xxxxxxxx, Číně, Xxxxx Xxxxxx, Xxxxxxxxx xxxxxxx x Thajsku xx xxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxx pro xxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxx xxxxx xxxxxxxxx x xxx, xxxxx x fretek
(oznámeno xxx xxxxxx X(2020) 2103)
(Xxxx s xxxxxxxx xxx XXX)
XXXXXXXX KOMISE,
s xxxxxxx na Xxxxxxx x fungování Xxxxxxxx xxxx,
x xxxxxxx xx xxxxxxxxxx Rady 2000/258/XX xx xxx 20. xxxxxx 2000 x xxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxxxxxx za xxxxxxxxx xxxxxxxx xxxxxxxxxx pro xxxxxxxxxxx sérologických xxxxx xxx sledování účinnosti xxxxxxxxxx xxxxx proti xxxxxxxxx&xxxx;(1), x xxxxxxx xx čl. 3 xxxx. 2 xxxxxxxxx xxxxxxxxxx,
xxxxxxxx x těmto xxxxxxx:
|
(1) |
Xxxxxxxxxx 2000/258/XX xxxxxx xxxxxxxxx Xxxxxx xxxxçxxxx xx xxxxxxxx sanitaire xxx xxxxxxxx (dále xxx „AFSSA“) xx xxxxxxxxxxxx Nancy jako xxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxxxx xxxxxxxx xxxxxxxxxx pro xxxxxxxxxxx xxxxxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxx očkovacích xxxxx xxxxx xxxxxxxxx. XXXXX xxxx xxxx xxxxxxxxx do Agence xxxxxxxxx de xxxxxxxx xxxxxxxxx de x’xxxxxxxxxxxx, xx x’xxxxxxxxxxxxx xx xx travail (xxxx xxx „XXXXX“) xx Xxxxxxx. |
|
(2) |
Xxxxxxxxxx 2000/258/XX xxxx xxxx stanoví, xx XXXXX xxxxxxx xxxxxxxxxx xx třetích xxxxxx, xxxxx xxxxxxxxxx xxxxxx x xxxxxxxxx xx xxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxx xxxxx vzteklině. |
|
(3) |
Příslušný xxxxx x Xxxxxxxx předložil xxxxxx x xxxxxxxxx xxxxxxxxxx „Núcleo xx Xxxxxxxxx xx Xxxxx xx Laboratório xx Xxxxxxxxx Clínica e Xxxxxxxxx do Xxxxxxxxx xx Xxêxxxxx Xxxxxxxxxx xx Xxxxxxxxxxxx xx Xãx Xxxxx“. XXXXX xxx xxxx xxxxxxxxx xxxxxxxxxxx příznivou xxxxxxxxx xxxxxx ze xxx 24. xxxxx 2019, xxxxxx xxxxxxxxxx Komisi. |
|
(4) |
Příslušný xxxxx Xxxx předložil xxxxxx x xxxxxxxxx xxxx xxxxxxxxxx: „Xxxx Xxxx Xxxxx Xxxxxxxxxxx Xxxxxxxxxxxxxx Co., Xxx (Xxxxxx)“ a „Animal Xxxxxxx Xxxxxxxxxx Xxxxxx xx the Xxxxxxxxx xx Xxxxxx Xxxxxx xx xxx Xxxxxxxxx Xxxxxxx xx Xxxxxxxxxxx Xxxxxxxx“. ANSES xxx xxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxx xx dne 24. xxxxx 2019, kterou xxxxxxxxxx Xxxxxx. |
|
(5) |
Xxxxxxxxx xxxxx Xxxx předložil xxxxxx x opětovné xxxxxxxxx xxxx laboratoří: „Xxxxxxxx Xxxxxxxxx Xxxxxxxxxx xxx Xxxxxx Rabies (Xxxxxxxxxx Xxxxxxxxxx for Xxxxxx xxx Xxxxxxxx Associated Xxxxxxxx)“ x „Centre xxx Xxxxxx Antibody Xxxxx xx xxx Xxxxxxxxxx of Xxxxxxxxxxxx xx the Military Xxxxxxxxxx Xxxxxxxx Xxxxxxxxx xx xxx Xxxxxxx xx Xxxxxxxx Medical Xxxxxxxx“. ANSES pro xxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxx xx xxx 24. xxxxx 2019, kterou xxxxxxxxxx Komisi. |
|
(6) |
Příslušný xxxxx Xxxxx Xxxxxx xxxxxxxxx xxxxxx x xxxxxxxxx xxxxxxxxxx „Rabies xxx Xxxxxxxx xxxxxxxxxxxx OIE xxxxxxxxx xxxxxxxxxx xx Xxxxxx and Xxxxx Xxxxxxxxxx Agency“. ANSES xxx xxxx xxxxxxxxx xxxxxxxxxxx příznivou xxxxxxxxx xxxxxx ze xxx 24. xxxxx 2019, xxxxxx xxxxxxxxxx Komisi. |
|
(7) |
Příslušný xxxxx Thajska xxxxxxxxx xxxxxx x xxxxxxxxx xxxxxxxxxx „Xxxxxxxx Xxxxxxxxx xx Animal Xxxxxx“. XXXXX xxx xxxx xxxxxxxxx vypracovala xxxxxxxxx xxxxxxxxx xxxxxx xx xxx 24. xxxxx 2019, xxxxxx xxxxxxxxxx Xxxxxx. |
|
(8) |
Xxxxxxxxx orgán Xxxxxxxxx xxxxx předložil žádost x xxxxxxxx xxxxxxxxx xxxxxxxxxx „Xxxxxxx xxx Xxxxxxx Control xxx Xxxxxxxxxx of the Xxxxxx Xxxxxxxxxx“. XXXXX xxx xxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxx xx dne 24. října 2019, xxxxxx xxxxxxxxxx Xxxxxx. |
|
(9) |
Xxxx xxxxxxxxxx xx xxxxx xxxx xxx schváleny xx xxxxxx xxxxxxxxx xxxxxxxxxxxxx testů xxx xxxxxxxxx xxxxxxxxx očkovacích xxxxx xxxxx xxxxxxxxx x psů, koček x xxxxxx. |
|
(10) |
Xxxxxxxx xxxxxxxxx xxxxx xxxxxxxxxxx xxxx x xxxxxxx xx xxxxxxxxxxx Xxxxxxx výboru xxx rostliny, xxxxxxx, xxxxxxxxx a xxxxxx, |
XXXXXXX XXXX XXXXXXXXXX:
Xxxxxx 1
X xxxxxxx x xx. 3 xxxx. 2 rozhodnutí 2000/258/XX xx xxx xxxxxxxxx sérologických xxxxx xx účelem sledování xxxxxxxxx xxxxxxxxxx látek xxxxx xxxxxxxxx u xxx, koček x xxxxxx xxxxxxxxx xxxx xxxxxxxxxx:
|
x) |
Xxxxxx de Xxxxxxxxx xx Raiva Xxxxxxxxxxx xx Xxxxxxxxx Xxxxxxx e Xxxxxxxxx xx Instituto xx Xxêxxxxx Xxxxxxxxxx Universidade xx Xãx Paulo Xx. Xxxx. Lineu Prestes, 1374, room 225 05508-000 Xãx Paulo Brazílie |
|
b) |
Xxxx Xxxx Xxxxx Biologicals Pharmaceutical Xx., Xxx (Xxxxxxx) 29 Xxxxxxxx Xxxx Xxxx. Xxxxxxxxxx Xxxxxxxx Xxxx, Xxxxxx District, Xxxxxx Xxxx |
|
c) |
Xxxxxx Disease Xxxxxxxxxx Center Xxxxxxxxx xx Xxxxxx Health, Xxxxxxxxx Xxxxxxx of Xxxxxxxxxxx Xxxxxxxx 21 Baishigang Street, Xxxxxx Xxxxxxxx Guangzhou, Guangdong Xxxx |
|
x) |
National Xxxxxxxxx Xxxxxxxxxx xxx Xxxxxx Xxxxxx (Xxxxxxxxxx Xxxxxxxxxx xxx Rabies xxx Wildlife Associated Xxxxxxxx) Xxxxxxxxx Xxxxxxxxxx Xxxxxxxx Xxxxxxxxx, Chinese Xxxxxxx xx Xxxxxxxxxxxx Sciences 666 Xxxxxxx Xxxx Xxxx, Xxxxxxx Xxxxxxx Xxxxxxxxxxx Xxxxxxxx, Xxxxxxxxx, Xxxxx, Čína |
|
x) |
Xxxxxx xxx Rabies Xxxxxxxx Xxxxx, Xxxxxxxxxx of Xxxxxxxxxxxx, Xxxxxxxx Xxxxxxxxxx Xxxxxxxx Xxxxxxxxx, Xxxxxxx xx Xxxxxxxx Medical Xxxxxxxx 666 Xxxxxxx Xxxx Xxxx, Jingyue Economy Xxxxxxxxxxx District Xxxxxxxxx, Xxxxx Xxxx |
|
x) |
Xxxxxx xxx Xxxxxxxx encephalitis XXX xxxxxxxxx xxxxxxxxxx xx the Animal xxx Xxxxx Xxxxxxxxxx Xxxxxx 177 Xxxxxxxx 8-ro, Xxxxxxxx-xx, Xxxxxxxxxxxxx-xx, 39660, Xxxxx Xxxxx |
|
x) |
Xxxxxxx for Xxxxxxx Xxxxxxx xxx Xxxxxxxxxx Rabies Xxxxxxxxxx 1600 Xxxxxxx Xxxx, XX, Xxxxxxx, GA 30333, Xxxxxxx státy xxxxxxxx |
|
x) |
The Xxxxxxxx Xxxxxxxxx xx Xxxxxx Health 50/2 Xxxxxxxxxx, Xxxxxx, Chatuchak Bangkok 10900 Xxxxxxx |
Xxxxxx 2
Toto rozhodnutí xx xxxxxx xxxxxxxx xxxxxx.
X Xxxxxxx xxx 14. xxxxx 2020.
Xx Xxxxxx
Xxxxxx XXXXXXXXXX
xxxxxx Xxxxxx
(1) Úř. věst. X 79, 30.3.2000, x. 40.